Anna Protopapas - Insider Trading & Ownership

Location
Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, MA
Summary
The estimated net worth of Anna Protopapas is at least $610K dollars as of June 20, 2025. Anna Protopapas is the Director of Nuvalent, Inc. and owns shares of Nuvalent, Inc. (NUVL) stock worth about $343K. Anna Protopapas is the Director of Mersana Therapeutics, Inc. and owns shares of Mersana Therapeutics, Inc. (MRSN) stock worth about $139K. Anna Protopapas is the Director of Dicerna Pharmaceuticals Inc and owns shares of Dicerna Pharmaceuticals Inc stock worth about $127K.
Signature
/s/ Nathan N. McConarty, attorney-in-fact
All Insider Reports
All Insider Reports

Ownership of Anna Protopapas

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NUVL Nuvalent, Inc. Director $343K Jun 18, 2025
MRSN Mersana Therapeutics, Inc. Director $139K -$16.5K -10.6% Jun 12, 2025
DRNA Dicerna Pharmaceuticals Inc Director $127K Jun 3, 2021

Insider Transactions Reported by Anna Protopapas:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.